Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 03-Apr-23 1:58 PM View:  | Temeng Kwaku Director | Core Laboratories NV (CLB) | 01-Apr-23 | Option Exercise | 5,485 | -- | -- | 127% 4.31K to 9.79K | |
| 03-Apr-23 1:41 PM View: | Straughen Michael Director | Core Laboratories NV (CLB) | 01-Apr-23 | Payment of Exercise | 2,524 | $22.05 | $55,654.20 | (12%) 21.52K to 18.99K | |
| 03-Apr-23 1:36 PM View: | Klingensmith Harvey Robert Director | Core Laboratories NV (CLB) | 01-Apr-23 | Option Exercise | 5,485 | -- | -- | 26% 20.74K to 26.23K | |
| 03-Apr-23 1:32 PM View: | Carnes Martha Z. Director | Core Laboratories NV (CLB) | 01-Apr-23 | Option Exercise | 5,485 | -- | -- | 22% 25.11K to 30.59K | |
| 03-Apr-23 1:38 PM View: | Murray Katherine Director | Core Laboratories NV (CLB) | 01-Apr-23 | Option Exercise | 5,485 | -- | -- | 100% 0 to 5.49K | |
| 03-Apr-23 1:41 PM View: | Straughen Michael Director | Core Laboratories NV (CLB) | 01-Apr-23 | Option Exercise | 5,485 | -- | -- | 34% 16.03K to 21.52K | |
| 03-Apr-23 2:04 PM View: | van Dijken Eeuwijk Monique Director | Core Laboratories NV (CLB) | 01-Apr-23 | Option Exercise | 5,485 | -- | -- | 47% 11.63K to 17.12K | |
| 04-Jan-23 4:55 PM View: | Hill Christopher Scott SVP & CFO | Core Laboratories NV (CLB) | 31-Dec-22 | Option Exercise | 31,688 | -- | -- | 73% 43.48K to 75.17K | |
| 04-Jan-23 4:50 PM View: | Daniels Kevin CAO & Treasurer | Core Laboratories NV (CLB) | 31-Dec-22 | Option Exercise | 6,000 | -- | -- | 81% 7.38K to 13.38K | |
| 04-Jan-23 5:02 PM View: | Schreffler Gwendolyn SVP | Core Laboratories NV (CLB) | 31-Dec-22 | Payment of Exercise | 4,722 | $20.27 | $95,714.90 | 17% 27.06K to 31.78K | |
| 04-Jan-23 4:50 PM View: | Daniels Kevin CAO & Treasurer | Core Laboratories NV (CLB) | 31-Dec-22 | Payment of Exercise | 2,361 | $20.27 | $47,857.50 | (18%) 13.38K to 11.02K | |
| 04-Jan-23 4:46 PM View: | Bruno Lawrence Chairman and CEO Director | Core Laboratories NV (CLB) | 31-Dec-22 | Payment of Exercise | 35,892 | $20.27 | $727,531.00 | (21%) 174.3K to 138.41K | |
| 04-Jan-23 4:55 PM View: | Hill Christopher Scott SVP & CFO | Core Laboratories NV (CLB) | 31-Dec-22 | Payment of Exercise | 12,470 | $20.27 | $252,767.00 | (17%) 75.17K to 62.7K | |
| 04-Jan-23 5:02 PM View: | Schreffler Gwendolyn SVP | Core Laboratories NV (CLB) | 31-Dec-22 | Option Exercise | 12,000 | -- | -- | (38%) 31.78K to 19.78K | |
| 04-Jan-23 4:46 PM View: | Bruno Lawrence Chairman and CEO Director | Core Laboratories NV (CLB) | 31-Dec-22 | Option Exercise | 91,212 | -- | -- | 110% 83.09K to 174.3K | |
| 02-Dec-22 1:32 PM View: | Daniels Kevin CAO & Treasurer | Core Laboratories NV (CLB) | 01-Dec-22 | Payment of Exercise | 56 | $21.50 | $1,204.00 | (1%) 5.14K to 5.08K | |
| 02-Dec-22 1:33 PM View: | Tattoli Mark Damian SVP, Gen Counsel & Secretary | Core Laboratories NV (CLB) | 01-Dec-22 | Option Exercise | 160 | -- | -- | 2% 6.85K to 7.01K | |
| 02-Dec-22 1:32 PM View: | Daniels Kevin CAO & Treasurer | Core Laboratories NV (CLB) | 01-Dec-22 | Option Exercise | 140 | -- | -- | 3% 5.0K to 5.14K | |
| 02-Dec-22 1:33 PM View: | Tattoli Mark Damian SVP, Gen Counsel & Secretary | Core Laboratories NV (CLB) | 01-Dec-22 | Payment of Exercise | 63 | $21.50 | $1,354.50 | (< 1%) 7.01K to 6.94K | |
| 03-Oct-22 12:34 PM View: | Tattoli Mark Damian SVP, Gen Counsel & Secretary | Core Laboratories NV (CLB) | 01-Oct-22 | Payment of Exercise | 276 | $13.48 | $3,720.48 | (4%) 7.34K to 7.06K | |
| 03-Oct-22 12:34 PM View: | Tattoli Mark Damian SVP, Gen Counsel & Secretary | Core Laboratories NV (CLB) | 01-Oct-22 | Option Exercise | 700 | -- | -- | 11% 6.64K to 7.34K | |
| 02-Aug-22 3:25 PM View: | Tattoli Mark Damian SVP, Gen Counsel & Secretary | Core Laboratories NV (CLB) | 01-Aug-22 | Payment of Exercise | 166 | $18.02 | $2,991.32 | (3%) 6.44K to 6.28K | |
| 02-Aug-22 3:25 PM View: | Tattoli Mark Damian SVP, Gen Counsel & Secretary | Core Laboratories NV (CLB) | 01-Aug-22 | Option Exercise | 370 | -- | -- | 6% 6.07K to 6.44K | |
| 02-May-22 3:33 PM View: | Tattoli Mark Damian SVP, Gen Counsel & Secretary | Core Laboratories NV (CLB) | 01-May-22 | Payment of Exercise | 174 | $26.00 | $4,524.00 | (3%) 6.25K to 6.08K | |
| 02-May-22 3:33 PM View: | Tattoli Mark Damian SVP, Gen Counsel & Secretary | Core Laboratories NV (CLB) | 01-May-22 | Option Exercise | 450 | -- | -- | 8% 5.8K to 6.25K | |
| 04-Apr-22 5:05 PM View: | Straughen Michael Director | Core Laboratories NV (CLB) | 01-Apr-22 | Payment of Exercise | 1,982 | $32.43 | $64,276.30 | (11%) 17.47K to 15.49K | |
| 04-Apr-22 5:06 PM View: | Temeng Kwaku Director | Core Laboratories NV (CLB) | 01-Apr-22 | Option Exercise | 4,307 | -- | -- | 100% 0 to 4.31K | |
| 04-Apr-22 5:05 PM View: | Klingensmith Harvey Robert Director | Core Laboratories NV (CLB) | 01-Apr-22 | Option Exercise | 4,307 | -- | -- | 26% 16.43K to 20.74K | |
| 04-Apr-22 5:03 PM View: | Barnett Gregory Barry Director | Core Laboratories NV (CLB) | 01-Apr-22 | Option Exercise | 4,307 | -- | -- | 15% 29.6K to 33.91K | |
| 04-Apr-22 5:07 PM View: | van Dijken Eeuwijk Monique Director | Core Laboratories NV (CLB) | 01-Apr-22 | Option Exercise | 4,307 | -- | -- | 59% 7.33K to 11.63K | |
| 04-Apr-22 5:05 PM View: | Straughen Michael Director | Core Laboratories NV (CLB) | 01-Apr-22 | Option Exercise | 4,307 | -- | -- | 33% 13.16K to 17.47K | |
| 04-Apr-22 5:04 PM View: | Carnes Martha Z. Director | Core Laboratories NV (CLB) | 01-Apr-22 | Option Exercise | 4,307 | -- | -- | 21% 20.8K to 25.11K | |
| 02-Mar-22 4:19 PM View: | Daniels Kevin CAO & Treasurer | Core Laboratories NV (CLB) | 01-Mar-22 | Option Exercise | 120 | -- | -- | 2% 4.93K to 5.05K | |
| 02-Mar-22 4:19 PM View: | Daniels Kevin CAO & Treasurer | Core Laboratories NV (CLB) | 01-Mar-22 | Payment of Exercise | 54 | $27.51 | $1,485.54 | (1%) 5.05K to 4.99K | |
| 02-Mar-22 4:21 PM View: | Tattoli Mark Damian SVP, Gen Counsel & Secretary | Core Laboratories NV (CLB) | 01-Mar-22 | Payment of Exercise | 50 | $27.51 | $1,375.50 | (< 1%) 5.98K to 5.93K | |
| 02-Mar-22 4:21 PM View: | Tattoli Mark Damian SVP, Gen Counsel & Secretary | Core Laboratories NV (CLB) | 01-Mar-22 | Option Exercise | 110 | -- | -- | 2% 5.87K to 5.98K | |
| 04-Jan-22 10:00 PM View: | Hill Christopher Scott SVP & CFO | Core Laboratories NV (CLB) | 31-Dec-21 | Payment of Exercise | 9,259 | $22.31 | $206,568.00 | (19%) 49.53K to 40.27K | |
| 04-Jan-22 5:53 PM View: | Schreffler Gwendolyn SVP | Core Laboratories NV (CLB) | 31-Dec-21 | Option Exercise | 4,700 | -- | -- | 69% 6.78K to 11.48K | |
| 04-Jan-22 10:00 PM View: | Bruno Lawrence Chairman and CEO Director | Core Laboratories NV (CLB) | 31-Dec-21 | Option Exercise | 46,233 | -- | -- | 124% 37.35K to 83.58K | |
| 04-Jan-22 5:53 PM View: | Schreffler Gwendolyn SVP | Core Laboratories NV (CLB) | 31-Dec-21 | Payment of Exercise | 1,850 | $22.31 | $41,273.50 | (16%) 11.48K to 9.63K | |
| 04-Jan-22 10:00 PM View: | Hill Christopher Scott SVP & CFO | Core Laboratories NV (CLB) | 31-Dec-21 | Option Exercise | 23,529 | -- | -- | 90% 26.0K to 49.53K | |
| 04-Jan-22 10:00 PM View: | Bruno Lawrence Chairman and CEO Director | Core Laboratories NV (CLB) | 31-Dec-21 | Payment of Exercise | 18,193 | $22.31 | $405,886.00 | (22%) 83.58K to 65.39K | |
| 04-Jan-22 5:52 PM View: | Daniels Kevin CAO & Treasurer | Core Laboratories NV (CLB) | 31-Dec-21 | Option Exercise | 3,800 | -- | -- | 93% 4.07K to 7.87K | |
| 04-Jan-22 5:52 PM View: | Daniels Kevin CAO & Treasurer | Core Laboratories NV (CLB) | 31-Dec-21 | Payment of Exercise | 1,496 | $22.31 | $33,375.80 | (19%) 7.87K to 6.37K | |
| 03-Dec-21 10:23 AM View: | Tattoli Mark Damian SVP, Gen Counsel & Secretary | Core Laboratories NV (CLB) | 01-Dec-21 | Payment of Exercise | 39 | $22.41 | $873.99 | (< 1%) 5.9K to 5.86K | |
| 03-Dec-21 10:23 AM View: | Tattoli Mark Damian SVP, Gen Counsel & Secretary | Core Laboratories NV (CLB) | 01-Dec-21 | Option Exercise | 160 | -- | -- | 3% 5.74K to 5.9K | |
| 03-Dec-21 10:24 AM View: | Daniels Kevin CAO & Treasurer | Core Laboratories NV (CLB) | 01-Dec-21 | Option Exercise | 140 | -- | -- | 6% 2.54K to 2.68K | |
| 03-Dec-21 10:24 AM View: | Daniels Kevin CAO & Treasurer | Core Laboratories NV (CLB) | 01-Dec-21 | Payment of Exercise | 56 | $22.41 | $1,254.96 | (2%) 2.68K to 2.63K | |
| 05-Oct-21 5:24 PM View: | Tattoli Mark Damian SVP, Gen Counsel & Secretary | Core Laboratories NV (CLB) | 01-Oct-21 | Payment of Exercise | 169 | $29.05 | $4,909.45 | (3%) 5.78K to 5.61K | (4%) |
| 05-Oct-21 5:24 PM View: | Tattoli Mark Damian SVP, Gen Counsel & Secretary | Core Laboratories NV (CLB) | 01-Oct-21 | Option Exercise | 700 | -- | -- | 14% 5.08K to 5.78K |
